CIK 0001253689
- Non-accelerated filer
- Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +1 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $285,501
- in 7 filings, $286K under 10b5-1 plans
Net −$285,501. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Brumm Joshua T −$160K Chief Executive Officer sold 3% of stake
- McNeill Jonathan −$77K President and COO sold 3% of stake
- Pinkas Jan −$12K Chief Scientific Officer sold 3% of stake
- Im Ellie Eunkyung −$11K Chief Medical Officer sold 3% of stake
- Bispham Barbara Harlin −$11K Reporting owner sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-08 | Invus Public Equities, L.P. 10% owner | Sale | −260,873 | $0.19 | $50K | 6,317,565 |
| 2024-08-07 | Invus Public Equities, L.P. 10% owner | Sale | −61,488 | $0.18 | $11K | 6,578,438 |
| 2024-08-06 | Invus Public Equities, L.P. 10% owner | Sale | −55,732 | $0.18 | $10K | 6,639,926 |
| 2024-08-05 | Invus Public Equities, L.P. 10% owner | Sale | −164,523 | $0.19 | $31K | 6,695,658 |
| 2024-08-02 | Invus Public Equities, L.P. 10% owner | Sale | −286,200 | $0.20 | $57K | 6,860,181 |
| 2024-08-01 | Invus Public Equities, L.P. 10% owner | Sale | −63,564 | $0.22 | $14K | 7,146,381 |
| 2024-07-30 | Invus Public Equities, L.P. 10% owner | Sale | −756,835 | $0.22 | $167K | 7,209,945 |
| 2024-07-29 | Invus Public Equities, L.P. 10% owner | Sale | −363,949 | $0.24 | $86K | 7,966,780 |
| 2024-07-26 | Invus Public Equities, L.P. 10% owner | Sale | −258,335 | $0.24 | $62K | 8,330,729 |
| 2023-02-24 | Invus Public Equities, L.P. 10% owner | Purchase | +100,000 | $1.70 | $170K | 8,589,064 |
| 2023-02-23 | Invus Public Equities, L.P. 10% owner | Purchase | +200,000 | $1.75 | $351K | 8,489,064 |
| 2023-02-22 | Invus Public Equities, L.P. 10% owner | Purchase | +150,000 | $1.79 | $269K | 8,289,064 |
| 2023-02-21 | Invus Public Equities, L.P. 10% owner | Purchase | +50,000 | $1.85 | $93K | 8,139,064 |
| 2023-02-17 | Invus Public Equities, L.P. 10% owner | Purchase | +200,000 | $1.71 | $341K | 8,089,064 |
| 2023-02-16 | Invus Public Equities, L.P. 10% owner | Purchase | +315,266 | $1.68 | $531K | 7,889,064 |
| 2023-02-15 | Invus Public Equities, L.P. 10% owner | Purchase | +1,000,000 | $2.16 | $2.2M | 7,573,798 |
| 2023-02-09 | Invus Public Equities, L.P. 10% owner | Purchase | +11,451 | $3.24 | $37K | 6,573,798 |
Page 1 of 1 · 17 trades